Lv1
64 积分 2025-11-12 加入
Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma
1个月前
已完结
METTL3-m 6 A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma
1个月前
已完结
New insights into the mechanism of resistance to lenvatinib and strategies for lenvatinib sensitization in hepatocellular carcinoma
1个月前
已完结
Platycodin D inhibits non-small cell lung cancer bone metastasis by inducing ferroptosis through miR-877-3P/PNMA5 regulatory axis
1个月前
已完结
WDR11-DT enhances radiosensitivity via promoting PARP1 degradation and homologous recombination deficiency
2个月前
已完结
Comparative analysis of sorafenib and lenvatinib on HepG2 cells and human umbilical vein endothelial cells: Involvement of transforming growth factor-β signaling in their molecular effects
4个月前
已完结
EGFR signaling pathway as therapeutic target in human cancers
6个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
6个月前
已完结
Predicting GD2 expression across cancer types by the integration of pathway topology and transcriptome data
9个月前
已关闭
The key roles of non-coding RNAs in the pathophysiology of hypertension
10个月前
已完结
皖公网安备34019202002308
